Fibrocor Therapeutics
MaRS Centre, West Tower
661 University Avenue, Suite 465
Toronto
Ontario
M5G 1M1
Canada
Tel: 647-260-7869
Website: http://bill@fibrocortherapeutics.com/
About Fibrocor Therapeutics
Fibrocor will focus on developing therapeutics for fibrotic diseases.
YEAR FOUNDED:
January 2017
LEADERSHIP:
Founders: Richard Gilbert, Jeff Wrana, and Darren Yuen
CEO: Mark Steedman
5 articles about Fibrocor Therapeutics
-
While the conditions surrounding the City by the Bay are in a negative light, there is still a significant amount of positive news coming out of the conference.
-
Fibrocor and Galapagos sign partnership in fibrosis
1/4/2019
Fibrocor Therapeutics L.P. and Galapagos NV announced a global partnership focused on a novel target for idiopathic pulmonary fibrosis (IPF) and other indications.
-
Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017.
-
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
-
Newly Created Fibrocor Therapeutics Makes Debut
1/17/2017